ErbB2 (HER2 or Neu or CD340) Antibody - FFPE Validated

Protein Function

Designed to help you assess ErbB2 (HER2), this antibody supports studies where protein context matters. ErbB2 is a pathway component whose activation state and localization can change after stimulation. Its behavior can reflect changes in differentiation state, stress, or remodeling of cellular architecture.

In some datasets and protocols, it is referenced by the gene symbol HER2.

Experimental Applications

Perturbations such as inhibitors or ligand stimulation can drive rapid shifts in localization or complex formation. Because regulation can be multi-layered, combining abundance and localization information can sharpen conclusions.

Many workflows benefit from tracking both signal intensity and compartment distribution, especially when the target participates in multi-protein assemblies. In oncology research models, expression shifts can accompany changes in adhesion, signaling, or differentiation state.

Common experimental questions that benefit from target tracking include:

• time-resolved changes following stimulation or inhibition
• localization shifts between cytoplasm, membrane, and nucleus
• condition-to-condition comparisons with matched controls

Workflow Perspective

For paraffin-embedded samples, fixation history and retrieval strategy matter; this option is aligned to those constraints. To keep comparisons consistent, align sample preparation steps and define a clear baseline for each series.

If your study spans multiple model systems, it can help to define a shared reference condition for ErbB2 so cross-sample contrasts stay meaningful.

The fixed-section version supports deeper biological narratives around ErbB2 (HER2) without overcomplicating setup.